A Longitudinal Study of Spontaneous Gut Decolonization of Carbapenem-resistant Gram-negative Bacteria in Neonatal and Pediatric Patients
- PMID: 35446811
- DOI: 10.1097/INF.0000000000003562
A Longitudinal Study of Spontaneous Gut Decolonization of Carbapenem-resistant Gram-negative Bacteria in Neonatal and Pediatric Patients
Abstract
Background: Antibiotic exposure may convert gut microbiome to reservoir of resistant organisms, including carbapenem-resistant Gram-negative bacteria (CRGNB). Little is known about natural history of spontaneous CRGNB decolonization of neonates/children and their risk to develop CRGNB infections.
Methods: Patients hospitalized in a tertiary care hospital (1 days to 16 years) found to be CRGNB colonized in weekly surveillance cultures during hospitalization (January 2018 to December 2019) were prospectively followed after discharge with monthly rectal cultures for 12 months after colonization until decolonization (3 consecutive negative rectal cultures, ≥1 week apart). Patient demographics, clinical characteristics and CRGNB infections were recorded. Polymerase chain reaction for carbapenemases was performed in patients colonized, after 3 negative cultures, at the day of the last negative and the day of the first new positive culture.
Results: One-hundred thirty patients (median age, 1.3 months; lower-upper quartile values, 0.8-6.9 months) were studied including 66 neonates (median age, 12.6 days; Q1-Q3, 5-18.5 days). Among patients >30 days old, 51.6% achieved decolonization within 6 months, and among neonates, 91% achieved decolonization within 6 months. By 12th month, 89% of >30 days and 100% of neonates were decolonized. Forty-four (33.9%) patients (59% >30 days and 9% neonates) developed CRGNB infection(s), mainly pneumonia (25%) and bloodstream infection (20.5%). Prolonged colonization (odds ratio [OR], 7.75; 95% confidence interval [CI], 2.10-28.58), duration of broad-spectrum antibiotic use (OR, 1.22; 95% CI, 1.11-1.34) and parenteral nutrition (OR, 4.53; 95% CI, 1.14-17.94) were associated with the development of CRGNB infection. Two patients (1.5%) were found by polymerase chain reaction colonized after 3 negative cultures.
Conclusions: Spontaneous decolonization occurs in most CRGNB colonized >30 days and all neonates within 12 months. One-third of colonized patients develop CRGNB infection(s). These findings may help optimize duration of contact precautions and empirical antimicrobial therapy for CRGNB colonized pediatric patients.
Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.
Conflict of interest statement
E.R. has received research grants from Astellas, Gilead and Pfizer Inc and is a scientific advisor and member of the speaker bureaux for Astellas, Gilead, Merck and Pfizer Inc. The other authors have no conflicts of interest to disclose.
Similar articles
-
Modifiable risk factors associated with later gut decolonization of carbapenem-resistant Gram-negative bacteria in children: a prospective cohort study.J Hosp Infect. 2023 Jun;136:75-84. doi: 10.1016/j.jhin.2023.03.024. Epub 2023 Apr 17. J Hosp Infect. 2023. PMID: 37075817
-
Active surveillance of carbapenem-resistant gram-negative bacteria to guide antibiotic therapy: a single-center prospective observational study.Antimicrob Resist Infect Control. 2022 Jun 22;11(1):89. doi: 10.1186/s13756-022-01103-0. Antimicrob Resist Infect Control. 2022. PMID: 35733230 Free PMC article.
-
Impact of active surveillance and infection control measures on carbapenem-resistant Gram-negative bacterial colonization and infections in intensive care.J Hosp Infect. 2018 Aug;99(4):396-404. doi: 10.1016/j.jhin.2018.05.010. Epub 2018 May 21. J Hosp Infect. 2018. PMID: 29792971
-
A systematic literature review and expert consensus on risk factors associated to infection progression in adult patients with respiratory tract or rectal colonisation by carbapenem-resistant Gram-negative bacteria.Rev Esp Quimioter. 2022 Oct;35(5):455-467. doi: 10.37201/req/062.2022. Epub 2022 Jul 21. Rev Esp Quimioter. 2022. PMID: 35859521 Free PMC article.
-
Guidelines for the diagnosis, treatment, prevention and control of infections caused by carbapenem-resistant gram-negative bacilli.J Microbiol Immunol Infect. 2023 Aug;56(4):653-671. doi: 10.1016/j.jmii.2023.01.017. Epub 2023 Feb 18. J Microbiol Immunol Infect. 2023. PMID: 36868960 Review.
Cited by
-
Carbapenem-Resistant and Extended-Spectrum β-Lactamase-Producing Enterobacterales in Children, United States, 2016-2020.Emerg Infect Dis. 2024 Jun;30(6):1104-1114. doi: 10.3201/eid3006.231734. Emerg Infect Dis. 2024. PMID: 38781979 Free PMC article.
References
-
- Catho G, Huttner BD. Strategies for the eradication of extended-spectrum beta-lactamase or carbapenemase-producing Enterobacteriaceae intestinal carriage. In: Expert Rev Anti-Infect Therapy. 2019;17:557–569.
-
- Willyard C. Expanded human gene tally reignites debate. Nature. 2018;558:354–355.
-
- Hall AB, Tolonen AC, Xavier RJ. Human genetic variation and the gut microbiome in disease. In: Nat Rev Genet. 2017;18:690–699.
-
- Cresci GA, Bawden E. Gut microbiome: what we do and don’t know. Nutri Clin Practice. 2015;30:734–746.
-
- Schmidt TSB, Raes J, Bork P. The human gut microbiome: from association to modulation. Cell. 2018;172:1198–1215.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical